Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 5/20 | 0.42 |
| ▸ | CXCR4 | P61073 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7869855 | 1.00 | CCR5 (0.42) | CCR5CXCR4MEN1KMT2AOPRM1 | |
| SCHEMBL7868450 | 0.96 | CCR5 (0.42) | CCR5MEN1KMT2AALDH1A1SIGMAR1 | |
| SCHEMBL7868448 | 0.96 | CCR5 (0.42) | CCR5MEN1KMT2AALDH1A1SIGMAR1 | |
| SCHEMBL7863096 | 0.92 | CCR5 (0.48) | CCR5SIGMAR1BCHEACHEBACE1 | |
| SCHEMBL7521940 | 0.91 | CCR5 (0.43) | CCR5MEN1KMT2AALDH1A1SIGMAR1 | |
| SCHEMBL7521934 | 0.91 | CCR5 (0.43) | CCR5MEN1KMT2AALDH1A1SIGMAR1 | |
| SCHEMBL7863308 | 0.90 | CCR5 (0.42) | CCR5 | |
| SCHEMBL7863310 | 0.90 | CCR5 (0.42) | CCR5 | |
| SCHEMBL7871201 | 0.90 | CCR5 (0.47) | CCR5CXCR4MEN1KMT2AALDH1A1 | |
| SCHEMBL7871198 | 0.90 | CCR5 (0.47) | CCR5CXCR4MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6303593-B1 | FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS | MERCK & CO., INC. | 2001-10-16 | — | — | US | claimed |
| US-6303593-B1 | FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS | MERCK & CO., INC. | 2001-10-16 | — | — | US | disclosed |